Renacom125 mg+125 mg+50 mg+75 mg+75 mg

Renacom is a combination herbal/nutraceutical supplement marketed for general urinary tract and prostate health support. It is a dietary/herbal supplement rather than an FDA-approved prescription drug, and its use is based on traditional herbal practice and limited/preliminary clinical evidence rather than established pharmaceutical indications.

• Traditional/adjunct use for urinary tract comfort: The cranberry and uva ursi components of Renacom are traditionally used to support urinary tract health and, in some traditions, to help reduce the recurrence of mild urinary discomfort in otherwise healthy adults. Clinical evidence for a consistent, clinically meaningful benefit is limited and mixed across studies.
• Traditional/adjunct use for lower urinary tract symptoms (LUTS) in men: The saw palmetto and pygeum bark components of Renacom are traditionally used, and used adjunctively in some settings, to help ease mild lower urinary tract symptoms associated with benign prostatic enlargement (e.g., urinary frequency, weak stream). Randomized trial evidence is inconsistent, with several well-conducted studies showing no significant benefit over placebo for saw palmetto monotherapy.
• General antioxidant/wellness support: The tomato (lycopene) component of Renacom is included as an antioxidant; epidemiological data associate dietary lycopene intake with prostate health, but direct outcome evidence from supplementation with this specific combination is limited.

Renacom is not intended to diagnose, treat, cure, or prevent any disease, and it should not be used as a substitute for medical evaluation of urinary or prostate symptoms.

Cranberry + Saw Palmetto + Pygeum Bark + Tomato + Uva Ursi is formulated by combining the following plant-derived ingredients; exact strengths per capsule/tablet vary by manufacturer, so the specific product label should always be checked:

• Cranberry (Vaccinium macrocarpon) fruit extract
• Saw Palmetto (Serenoa repens) berry extract
• Pygeum Bark (Prunus africana) extract
• Tomato (Solanum lycopersicum) extract, standardized for lycopene
• Uva Ursi (Arctostaphylos uva-ursi) leaf extract

Renacom is an oral herbal combination supplement that brings together five plant-derived ingredients traditionally associated with urinary tract and male prostate health: cranberry and uva ursi for urinary tract support, saw palmetto and pygeum bark for prostate/urinary symptom support in men, and tomato as a source of the antioxidant lycopene. It is sold in Bangladesh as an over-the-counter herbal/dietary supplement, typically in capsule or tablet form, and is not a regulated prescription medicine.

Herbal/Nutraceutical Combination — Urinary Tract & Prostate Health Supplement (Renacom)

Cranberry + Saw Palmetto + Pygeum Bark + Tomato + Uva Ursi combines several distinct plant-derived mechanisms relevant to urinary tract and prostate health:

• Cranberry: contains proanthocyanidins (PACs) thought to reduce adherence of certain bacteria (notably E. coli) to the urinary tract lining, which is the proposed basis for its traditional use in urinary tract support.
• Uva Ursi: contains arbutin, which is converted in the body to hydroquinone derivatives with mild urinary antiseptic and astringent activity in alkaline urine; traditionally used short-term for urinary comfort.
• Saw Palmetto: contains fatty acids and phytosterols proposed to have mild anti-inflammatory and weak anti-androgenic (5-alpha-reductase inhibiting) activity, the traditional rationale for use in benign prostatic symptom relief.
• Pygeum Bark: contains phytosterols (e.g., beta-sitosterol) with proposed anti-inflammatory and anti-proliferative effects on prostate tissue, traditionally used for lower urinary tract symptom relief in men.
• Tomato (Lycopene): a carotenoid antioxidant that scavenges reactive oxygen species; associated in epidemiological studies with prostate tissue health.

Overall clinical-outcome evidence for Cranberry + Saw Palmetto + Pygeum Bark + Tomato + Uva Ursi as a fixed combination is limited and largely extrapolated from studies of the individual ingredients rather than the combination itself.

Renacom is taken by mouth, generally with food and a full glass of water to reduce the chance of stomach upset and to support urinary tract flushing. Capsules/tablets should be swallowed whole and not crushed or chewed unless the label states otherwise.

Renacom has the following well-recognized interaction concerns, mainly related to its saw palmetto and uva ursi components:

• Anticoagulants/antiplatelet agents (e.g., warfarin, aspirin, clopidogrel, NSAIDs): saw palmetto has been associated with a mild additive bleeding risk; concurrent use of Renacom with these medicines should be discussed with the prescriber, and Renacom should be discontinued before scheduled surgery per standard perioperative supplement guidance.
• Hormonal medicines (e.g., hormonal contraceptives, hormone replacement therapy, 5-alpha-reductase inhibitors such as finasteride/dutasteride): saw palmetto's mild anti-androgenic activity could theoretically add to or interfere with these therapies; use with medical guidance if relevant.
• PSA (prostate-specific antigen) testing: saw palmetto may lower measured PSA levels, which can interfere with prostate cancer screening/monitoring interpretation; inform the physician about Renacom use before PSA testing.
• Other urinary alkalinizing/acidifying agents: uva ursi's activity depends on alkaline urine; concurrent use of substances that acidify urine (e.g., high-dose vitamin C) may reduce its traditional effect.

Reported side effects of Renacom are generally mild and relate mainly to its individual herbal components:

• Gastrointestinal upset, mild nausea, or stomach discomfort
• Headache or dizziness
• Mild dry mouth
• Occasional decreased libido (associated with saw palmetto)
• Rare allergic reactions (rash, itching, swelling) — see Contraindications

Excessive or prolonged use of the uva ursi component in particular has been associated with gastrointestinal irritation; see Duration of Treatment and Precautions and Warnings.

Pregnancy: Renacom is not recommended during pregnancy. Several of its components, particularly uva ursi and saw palmetto, have limited safety data in pregnancy and potential hormonal activity; use only if clearly needed and only under direct medical guidance, with potential benefit weighed against potential risk to the fetus.

Lactation: There is insufficient reliable safety data on the use of Renacom during breastfeeding. As a precaution, breastfeeding mothers should consult a physician before using Renacom and should not use it without medical advice.

• Bleeding risk: use caution with concurrent anticoagulant/antiplatelet therapy; discuss with prescriber and discontinue before scheduled surgery (see Interactions).
• Hormone-sensitive conditions: saw palmetto's mild anti-androgenic activity means Renacom should be used with medical guidance in men with a relevant hormone-sensitive history, and may interfere with PSA test interpretation in men being monitored for prostate conditions (see Interactions).
• Duration of uva ursi use: the uva ursi component is intended for short-term, intermittent use; it should not be used continuously for prolonged periods without medical guidance (see Duration of Treatment).
• Evidence limitations: clinical evidence supporting meaningful symptomatic benefit from this specific combination is limited and preliminary; Renacom should be regarded as a supportive/adjunct product, not a proven treatment.
• Medical evaluation still needed: men with lower urinary tract symptoms should undergo appropriate medical evaluation, including prostate cancer screening as clinically indicated, rather than relying solely on Renacom or any supplement.
• Not a substitute for UTI treatment: Renacom must not be used to delay or replace evidence-based antibiotic treatment of a confirmed urinary tract infection (see Contraindications).

Specific overdose data for Renacom as a combination product are not well established. Excessive intake, particularly of the uva ursi component, may increase the likelihood of gastrointestinal upset or other side effects (see Side Effects). If overdose is suspected, or if severe symptoms such as persistent vomiting, severe abdominal pain, or allergic reaction occur, seek immediate medical attention or contact a poison control center/emergency services; do not attempt specific home treatment.

Store at room temperature (below 30°C), away from light and moisture. Keep out of reach of children.

• Elderly: Renacom is commonly used by older men for prostate/urinary comfort; general precautions regarding bleeding risk and hormone-sensitive conditions apply (see Precautions and Warnings).
• Renal impairment: well-established dose adjustment data are lacking; use with caution and medical supervision.
• Hepatic impairment: well-established dose adjustment data are lacking; use with caution and medical supervision, particularly given limited long-term safety data on the uva ursi component.
• Pregnancy and lactation: see Pregnancy and Lactation section — use is not recommended without direct medical guidance.
• Children: not recommended; see Pediatric Uses.

When used for general urinary tract or mild prostate symptom support, Renacom is typically trialed for several weeks (commonly 4–8 weeks) before any symptomatic benefit is assessed, consistent with the slower onset typical of herbal supplements. The uva ursi component specifically is intended for short-term, intermittent use — traditional guidance limits continuous use to about 1–2 weeks at a time, with breaks between courses — rather than continuous long-term daily use, unless a physician specifically advises otherwise. Ongoing or worsening urinary symptoms should prompt medical evaluation rather than continued self-use of Renacom alone.

Herbal/Nutraceutical combination — urinary tract and prostate health support (Cranberry + Saw Palmetto + Pygeum Bark + Tomato + Uva Ursi: cranberry, saw palmetto, pygeum bark, tomato/lycopene, and uva ursi extracts)

Cranberry + Saw Palmetto + Pygeum Bark + Tomato + Uva Ursi acts through multiple complementary plant-derived mechanisms rather than a single defined pharmacological pathway: reduced bacterial adhesion in the urinary tract (cranberry), mild urinary antiseptic/astringent activity (uva ursi), mild anti-inflammatory and weak anti-androgenic activity supporting prostate/urinary comfort (saw palmetto and pygeum bark), and antioxidant activity (tomato/lycopene). See Pharmacology for details of each component's proposed mechanism.

Renacom is formulated for adult use and is not recommended for use in children or adolescents. Safety and efficacy of Renacom in the pediatric population have not been established, and pediatric lower urinary tract symptoms should be evaluated and managed by a pediatrician rather than treated with this supplement.